XAIMED ‘FUNDUS-CVD AI’ Designated for Deferment in New Health Technology AssessmentAdmin XAIMEDOct 131 min read2025-09-25_[한경잡앤조이] [보건산업혁신창업센터 유망기업, 혁신 DNA 미래를 설계하다] 자이메드, 안저기반 동맥경화 AI 솔루션 신의료기술 평가 유예 . Download • 1.24MBhttps://magazine.hankyung.com/job-joy/article/202509245455d
Comments